On May 11, 2022 NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the "Company"), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, reported that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in the following conferences (Press release, Nanobiotix, MAY 11, 2022, View Source [SID1234614243]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Global Healthcare Conference

Presentation Date: Monday, May 23rd, 2022
Time: 10:45 AM ET
Location: New York, New York, USA
H.C. Wainwright Global Investment Conference

Presentation Date: Wednesday, May 25th, 2022
Time: 8:30 AM ET
Location: Virtual and Miami, Florida, USA
A live audio webcast of each presentation will be available on the events page of the Investors section of the Company’s website. A replay will be available on the Nanobiotix website within 48 hours after each event. The Company’s corporate presentation can be downloaded here.